PEDIATRICS Vol. 101 No. 3 March 1998, pp. 369-376
Received Mar 31, 1997; accepted Aug 27, 1997.
,
From the Departments of * Pediatrics and
Biostatistics,
University of Turku, Turku, Finland.
Objective. To determine the outcome of Finnish children and adolescents with idiopathic dilated cardiomyopathy (IDCM) and factors that might be useful as prognostic indicators.
Methodology. The clinical profile and course of 62 Finnish children and adolescents (median age, 13 months; range, 1 day to 20 years) with IDCM in 1980 to 1991 were evaluated to detect factors that might predict outcome. Factors studied included age, gender, family history, previous viral illness, and symptoms and signs at presentation. Furthermore, data on serial electrocardiographic, echocardiographic, and chest x-ray examinations, histologic findings, and treatments were analyzed.
Results. During a mean (±SD) follow-up of 3.9 ± 4.5 years (range, 1 day to 25 years), 10 patients (16%) recovered,
17 (27%) had residual disease, 4 (6.4%) underwent heart
transplantation, and 31 (50%) died. Infants (<1 year of age) and
adolescent (
15 years of age) male patients with progressing symptoms
of left ventricular failure after initiation of medical therapy tended to have the poorest outcome. However, in multivariate analysis, only
histologic evidence of endocardial fibroelastosis, clinical signs of
right ventricular failure at presentation, and the need for
anticoagulative therapy during follow-up, the last an expression of a
severely impaired left ventricular systolic function, appeared to be
significant predictors of long-term outcome.
Conclusions. Our study confirms that the outcome of children with IDCM still remains poor. However, a group of patients, mainly infants, make a full recovery. Adolescent male patients as well as infants suffering from endocardial fibroelastosis with persisting symptoms of congestive heart failure after initiation of medical therapy tend to have the poorest outcome. These patients need a careful follow-up at short time intervals and, in the case of lacking response to medical treatment with resulting growth failure and/or poor quality of life, should be offered urgent heart transplantation.
Key words: cardiomyopathy, congestive, child, adolescent, prognosis.
This article has been cited by other articles:
![]() |
R. E. Andrews, M. J. Fenton, D. A. Ridout, M. Burch, and on Behalf of the British Congenital Cardiac Associ New-Onset Heart Failure Due to Heart Muscle Disease in Childhood: A Prospective Study in the United Kingdom and Ireland Circulation, January 1, 2008; 117(1): 79 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. F. Daubeney, A. W. Nugent, P. Chondros, J. B. Carlin, S. D. Colan, M. Cheung, A. M. Davis, C.W. Chow, R. G. Weintraub, and on behalf of the National Australian Childhood Car Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study Circulation, December 12, 2006; 114(24): 2671 - 2678. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Tsirka, K. Trinkaus, S.-C. Chen, S. E. Lipshultz, J. A. Towbin, S. D. Colan, V. Exil, A. W. Strauss, and C. E. Canter Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation J. Am. Coll. Cardiol., July 21, 2004; 44(2): 391 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Maguire, H. Wakimoto, V. V. Patel, P. E. Hammer, K. Gauvreau, and C. I. Berul Implications of ventricular arrhythmia vulnerability during murine electrophysiology studies Physiol Genomics, September 29, 2003; 15(1): 84 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Lipshultz, L. A. Sleeper, J. A. Towbin, A. M. Lowe, E. J. Orav, G. F. Cox, P. R. Lurie, K. L. McCoy, M. A. McDonald, J. E. Messere, et al. The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States N. Engl. J. Med., April 24, 2003; 348(17): 1647 - 1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Berul, B. K. McConnell, H. Wakimoto, I. P.G. Moskowitz, C. T. Maguire, C. Semsarian, M. M. Vargas, J. Gehrmann, C. E. Seidman, and J. G. Seidman Ventricular Arrhythmia Vulnerability in Cardiomyopathic Mice With Homozygous Mutant Myosin-Binding Protein C Gene Circulation, November 27, 2001; 104(22): 2734 - 2739. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Mainwaring, R. M. Healy, J. D. Murphy, and W. I. Norwood Norwood/Batista operation for a newborn with dilated myopathy of the left ventricle J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 612 - 615. [Full Text] [PDF] |
||||
![]() |
D. N. Rosenthal Cardiomyopathy in Infants: A Brief Overview NeoReviews, August 1, 2000; 1(8): e139 - 145. [Full Text] |
||||
![]() |
P. J. del Nido EDITORIAL: PARTIAL LEFT VENTRICULECTOMY FOR DILATED CARDIOMYOPATHY IN CHILDREN J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 918 - 919. [Full Text] [PDF] |
||||